Abstract:The underlying pathophysiology of Parkinson's disease is complex, but mitochondrial dysfunction has an established and prominent role. This is supported by an already large and rapidly growing body of evidence showing that the role of mitochondrial (dys)function is central and multifaceted. However, there are clear gaps in knowledge, including the dilemma of explaining why inherited mitochondriopathies do not usually present with parkinsonian symptoms. Many aspects of mitochondrial function are potential therapeutic targets, including reactive oxygen species production, mitophagy, mitochondrial biogenesis, mitochondrial dynamics and trafficking, mitochondrial metal ion homeostasis, sirtuins, and endoplasmic reticulum links with mitochondria. Potential therapeutic strategies may also incorporate exercise, microRNAs, mitochondrial transplantation, stem cell therapies, and photobiomodulation. Despite multiple studies adopting numerous treatment strategies, clinical trials to date have generally failed to show benefit. To overcome this hurdle, more accurate biomarkers of mitochondrial dysfunction are required to detect subtle beneficial effects. Furthermore, selecting study participants early in the disease course, studying them for suitable durations, and stratifying them according to genetic and neuroimaging findings may increase the likelihood of successful clinical trials. Moreover, treatments involving combined approaches will likely better address the complexity of mitochondrial dysfunction in Parkinson's disease. Therefore, selecting the right patients, at the right time, and using targeted combination treatments, may offer the best chance for development of an effective novel therapy targeting mitochondrial dysfunction in Parkinson's disease.

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

Progress relating to mitochondria dysfunction and Parkinson disease

Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson’s Disease

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment

Dysregulation of autophagy and mitochondrial function in Parkinson's disease.

Targeting mitochondria with small molecules: A promising strategy for combating Parkinson's disease

Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review)

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Mitochondrial Contribution to Parkinson's Disease Pathogenesis

Role of mitochondrial damage and repair in Parkinson′s disease

New insights into the complex role of mitochondria in Parkinson’s disease

Mitochondrial Function and Parkinson’s Disease: From the Perspective of the Electron Transport Chain

The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease

Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson's Disease